Management of Prostate Cancer in Central China
Comparisons of Management and Outcome of Prostate Cancer in Central China Between 2003 and 2008: A Multi-institutional Report
Sponsor: Anyang Regional Hospital
Listed as NCT01614548, this observational or N/A phase trial focuses on Prostate Cancer and remains completed. Sponsored by Anyang Regional Hospital, it has been updated 8 times since 2003, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
8 versions recorded-
Mar 2026 — Present [monthly]
Completed
-
Sep 2024 — Mar 2026 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Nov 2023 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Nov 2023 [monthly]
Completed
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Jan 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Anyang Regional Hospital
- Center hospital of Nanyang
- Center hospital of Shangqiu
- First People's Hospital of Kaifeng
- Henan Cancer Hospital
- Luoyang Central Hospital
- People's Hospital of Zhengzhou University
- The First Affiliated Hospital of Zhengzhou University
- Third Affiliated Hospital of Zhengzhou University
- Xinyang Central Hospital
- Zhengzhou University
- Zhoukou Central Hospital
- Zhumadian Central Hospital
For direct contact, visit the study record on ClinicalTrials.gov .